Personalis to Announce Second Quarter 2024 Financial Results
24 Luglio 2024 - 10:01PM
Business Wire
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics
for cancer, announced today that it will release its second quarter
2024 financial results on Wednesday, August 7, 2024. In conjunction
with the release, Personalis will host a conference call and
webcast that day at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time
to discuss its financial results and recent highlights.
Interested parties may access the call by dialing 800-717-1738
for domestic callers or 646-307-1865 for international callers. The
webinar of the call may be accessed by visiting the Events section
of the company's website at investors.personalis.com. A replay of
the webinar will be available shortly after the conclusion of the
call and will be archived on the company's website.
About Personalis, Inc.
At Personalis, we are transforming the active management of
cancer through breakthrough personalized testing. We aim to drive a
new paradigm for cancer management, guiding care from biopsy
through the life of the patient. Our highly sensitive assays
combine tumor-and-normal profiling with proprietary algorithms to
deliver advanced insights even as cancer evolves over time. Our
products are designed to detect minimal residual disease (MRD) and
recurrence at the earliest timepoints, enable the selection of
targeted therapies based on ultra-comprehensive genomic profiling,
and enhance biomarker strategy for drug development. Personalis is
based in Fremont, California. To learn more, visit
www.personalis.com and connect with us on LinkedIn and X
(Twitter).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240724474751/en/
Investors: Caroline Corner investors@personalis.com
415-202-5678
Media: pr@personalis.com
Grafico Azioni Personalis (NASDAQ:PSNL)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Personalis (NASDAQ:PSNL)
Storico
Da Dic 2023 a Dic 2024